UK Medtechs Say Conditional Reimbursement Will Open Doors To Innovation Adoption
As the UK NHS Medtech Funding Mandate finally becomes live, the medtech industry is pressing the case for another mechanism that will allow more innovation onto the UK market.
You may also be interested in...
A new remit for the NHS’ innovation vehicles, hopes for Integrated Care Systems and a new diagnostics trends report from Deloitte were on the agenda at a UK life sciences sector policy conference.
Better uptake of medtech in tackling cardiovascular disease can bring benefits across the entire pathway of care, say UK CVD companies, who are urging the government to improve levels of technology adoption.
Evolving health care demands, digital innovation and the need to work within tighter budgets have prompted the UK’s NICE to reset its strategy for the coming five years.